-
Congresswoman Dingell Honored as Innovator in Biotechnology
biospectrumasia
April 08, 2019
BIO’s Innovator in Biotechnology award recognizes Members of Congress who have been collaborative partners, advocates, and champions of the biotechnology and life sciences industries.
-
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer
pharmafocusasia
March 20, 2019
SOTIO, a biotechnology company owned by the PPF Group, presented results from SOV02, its Phase II clinical trial evaluating DCVAC/OvCa, an active cellular immunotherapy product, in patients with recurrent ovarian cancer at 2019 SGO’s 50th Annual Meeting o
-
Goodwin Biotechnology Expands Capacity
pharmafocusasia
March 14, 2019
Invests in doubling space available for cGMP capacity as it readies for further expansion of its biopharma manufacturing business
-
European firms fuel growth in patent applications
europeanpharmaceuticalreview
March 14, 2019
Pharmaceutical and biotechnology patent applications increased by 13 percent last year, with over 6,000 applications coming from European companies…
-
Haselmeier Acquires Drug Manufacturing License and Now Offers Assembly, Labelling and Packaging Services to Pharmaceutical and Biotechnology Companies
b3cnewswire
February 15, 2019
Haselmeier is a leading solution provider for self-injection devices. As an innovative and strategic partner for pharmaceutical and biotechnology companies...
-
Bio S&T - A New Platform for the Introduction & Exchanges in Biopharmaceutical Industry
en-cphi.cn
January 30, 2019
Bio S&T will be held concurrently with CPhI China 2019 at SNIEC on June 18-20 2019.
-
Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies
pharmafocusasia
January 21, 2019
Obsidian Therapeutics, a biotechnology company developing cell therapies with pharmacologic operating systems, today announced a strategic collaboration with ....
-
Volumes Low for Unprotected Left Main PCI
drugs
January 03, 2019
Unprotected left main (ULM) percutaneous coronary intervention (PCI) procedures represented less than 1 percent of all PCIs in clinical practice in the United States from 2009 through 2016, according to a study published online Jan. 2 in JAMA Cardiology..
-
WuXi Biologics Advances Cell Culture Productivity
contractpharma
December 13, 2018
WuXi Biologics has advanced cell culture productivity for an Fc-fusion protein. The cell culture has a productivity of 2.5g/L/day and 51g/L bioreactor volume in a 20-day continuous cell culture process called WuXiUP (Ultra-high Productivity).
-
Thermo Fisher Opens Shanghai Bioprocess Design Center
contractpharma
December 03, 2018
Thermo Fisher Scientific opened its first Bioprocess Design Center in Shanghai, China as part of an effort to connect and collaborate with biologic developers to design optimal bioprocessing solutions.